DSM and Firmenich have jointly launched the exchange offer to DSM shareholders as part of a merger of equals to create DSM-Firmenich.
The Managing Board and Supervisory Board of DSM and the Board of Directors of Firmenich unanimously support the offer. DSM and Firmenich shareholders have already approved the transactions to establish DSM-Firmenich.
The number of outstanding shares on 22 November 2022, the convocation date, was 217,095,579.
The number of outstanding shares on 26 December 2022, the record date, was 217,114,307.
More information, including recordings of webcasts to investors and media, plus all the documents associated with this transaction are available at www.creator-innovator.com.
The EGM for DSM shareholders was held in Heerlen in the Netherlands on Monday 23 January 2023. Shareholders voted to approve all the resolutions.
DSM and Firmenich held a joint webcast for analysts and investors on Tuesday 22 November to provide an update on the progress of the merger made so far.